Frontlines

Frontlines Image © 2002 Nature Publishing Group Seeing cancer in real time? Researchers at University of California's Jonsson Cancer Center in Los Angeles have developed the first viral 'searchlight' that can hunt down prostate metastases, including those too small to appear on conventional detection scans (J.Y. Adams et al., "Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging," Nature Medicine, 8:891-7, August 2

Written byA. J. S. Rayl
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Seeing cancer in real time? Researchers at University of California's Jonsson Cancer Center in Los Angeles have developed the first viral 'searchlight' that can hunt down prostate metastases, including those too small to appear on conventional detection scans (J.Y. Adams et al., "Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging," Nature Medicine, 8:891-7, August 2002). The team engineered a disabled adenovirus to 'light up' when it detected prostate cancer cells based on the prostate-specific antigen protein in mice. Using luciferase and a charged-coupled device, the researchers watched as the prostate-targeted virus located prostate cancer cells in primary tumors, as well as distant metastases in the lungs and spines of laboratory mice, making them appear as hot spots. "We can deliver a targeted virus into a lab model and demonstrate that it is expressed only in prostate cancer cells," says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies